High-throughput drug screening identifies SMAC mimetics as enhancers of NK cell cytotoxicity in chronic myeloid leukemia.
Nygren PJ, Bouhlal JOV, Jokinen E, Forstén S, Laajala E, Dias DAA, Adnan Awad S, Ianevski A, Klievink J, Lähteenmäki H, Kuusanmäki H, Myllymäki M, Kasanen T, Saeed K, Lee DA, Flagship I, Hjorth-Hansen H, Aittokallio T, Dufva O, Mustjoki S.
Nygren PJ, et al. Among authors: dias daa.
Blood. 2025 Jan 10:blood.2024025286. doi: 10.1182/blood.2024025286. Online ahead of print.
Blood. 2025.
PMID: 39792962